Report cover image

U.S. Uterine Fibroids Treatment Devices Market Growth, Size, Trends Analysis - By Technology, By Mode of Treatment - Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Publisher SPER Market Research Pvt. Ltd.
Published Sep 06, 2025
Length 136 Pages
SKU # SPER20519988

Description

U.S. Uterine Fibroids Treatment Devices Market Introduction and Overview

According to SPER market research, ‘U.S. Uterine Fibroids Treatment Devices Market Growth, Size, Trends Analysis – By Technology, By Mode of Treatment – Regional Outlook, Competitive Strategies and Segment Forecast to 2034’ state that the U.S. Uterine Fibroids Treatment Devices Market is predicted to reach 7.27 billion by 2034 with a CAGR of 9.52%.

Uterine fibroid treatment devices are medical tools utilized to reduce or eliminate non-cancerous growths in the uterus, referred to as fibroids. These devices provide minimally invasive alternatives to traditional surgical methods. Examples include instruments for uterine fibroid embolization (UFE), which obstruct the blood flow to fibroids, leading to their shrinkage. Others utilize focused ultrasound or radiofrequency ablation to heat and destroy fibroid tissue.

Restraints: Advanced treatment devices such as magnetic resonance-guided focused ultrasound (MRgFUS), robotic-assisted surgical systems, and radiofrequency ablation (RFA) devices demand sophisticated technology, leading to elevated manufacturing and acquisition costs. These devices are comprised of precision-engineered components, high-intensity imaging systems, and AI-driven controls, rendering them considerably more costly than conventional surgical instruments.

Scope of the report:

Report Metric Details
Market size available for years 2021-2034
Base year considered 2024
Forecast period 2025-2034

Segments covered
By Technology, By Mode of Treatment

Regions covered
Northeast, Midwest, West, South

Companies Covered
Medtronic, Stryker, Boston Scientific Corporation, Insightec, CooperSurgical Inc, Hologic, Inc, CONMED Corporation, Merit Medical Systems, Minerva Surgical, Inc.

U.S. Uterine Fibroids Treatment Devices Market Segmentation:

By Technology: Based on the Technology, U.S. Uterine Fibroids Treatment Devices Market is segmented as; Surgical Techniques, Laparoscopic Techniques, Ablation Techniques, Embolization Techniques.

By Mode of Treatment: Based on the Mode of Treatment, U.S. Uterine Fibroids Treatment Devices Market is segmented as; Invasive Treatment, Minimally Invasive Treatment, Non-invasive Treatment.

By Region: This research also includes data for Northeast, Midwest, West, South.

Table of Contents

136 Pages
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPERs internal database
2.1.4. Premium insight from KOLs
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTERs Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. U. S. Uterine Fibroids Treatment Devices Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in U. S. Uterine Fibroids Treatment Devices Market
7. U. S. Uterine Fibroids Treatment Devices Market, By Technology (USD Million) 2021-2034
7.1. Surgical Techniques
7.1.1. Hysterectomy
7.1.2. Myomectomy
7.2. Laparoscopic Techniques
7.2.1. Laparoscopic Myomectomy
7.2.2. Myolysis
7.3. Ablation Techniques
7.3.1. Microwave Ablation
7.3.2. Hydrothermal Ablation
7.3.3. Cryoablation
7.3.4. Ultrasound Ablation
7.4. Embolization Techniques
8. U. S. Uterine Fibroids Treatment Devices Market, By Mode of Treatment (USD Million) 2021-2034
8.1. Invasive Treatment
8.2. Minimally Invasive Treatment
8.3. Non-invasive Treatment
9. U. S. Uterine Fibroids Treatment Devices Market, (USD Million) 2021-2034
9.1. U. S. Uterine Fibroids Treatment Devices Market Size and Market Share
10. U. S. Uterine Fibroids Treatment Devices Market, By Region, (USD Million) 2021-2034
10.1. Northeast
10.2. Midwest
10.3. West
10.4. South
11. Company Profile
11.1. Medtronic
11.1.1. Company details
11.1.2. Financial outlook
11.1.3. Product summary
11.1.4. Recent developments
11.2. Stryker
11.2.1. Company details
11.2.2. Financial outlook
11.2.3. Product summary
11.2.4. Recent developments
11.3. Boston Scientific Corporation
11.3.1. Company details
11.3.2. Financial outlook
11.3.3. Product summary
11.3.4. Recent developments
11.4. Insightec
11.4.1. Company details
11.4.2. Financial outlook
11.4.3. Product summary
11.4.4. Recent developments
11.5. CooperSurgical Inc
11.5.1. Company details
11.5.2. Financial outlook
11.5.3. Product summary
11.5.4. Recent developments
11.6. Hologic, Inc
11.6.1. Company details
11.6.2. Financial outlook
11.6.3. Product summary
11.6.4. Recent developments
11.7. CONMED Corporation
11.7.1. Company details
11.7.2. Financial outlook
11.7.3. Product summary
11.7.4. Recent developments
11.8. Merit Medical Systems
11.8.1. Company details
11.8.2. Financial outlook
11.8.3. Product summary
11.8.4. Recent developments
11.9. Minerva Surgical, Inc
11.9.1. Company details
11.9.2. Financial outlook
11.9.3. Product summary
11.9.4. Recent developments
11.10. Others
12. Conclusion
13. List of Abbreviations
14. Reference Links

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us